🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Macular Oedema

Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema NCT04910503Phase 41 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: Dexamethasone intravitreal implant, Fluocinolone Acetonide Intravitreal Implant A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) NCT07425522Phase 112 sites📍 Peoria📍 Beverly Hills📍 Walnut Creek Genentech, Inc. · Tests: RO7823653, Faricimab Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study NCT07821450n/a1 site📍 Istanbul Abdulkadir Küçük · Tests: Repeated intravitreal anti-VEGF injection with eyelid speculum Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery NCT07178639NA1 site📍 Kolín Nemocnice Kolín · Tests: Bromfenac 0.09 % Ophthalmic Solution, Nepafenac 0.3% Oph Susp, diclofenac 0.1% ophthalmic susp. Effect of Video Viewing on Intravitreal Injection Experience NCT07002372NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Procedure video viewing DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information. NCT07308639n/a1 site📍 Leverkusen Bayer · Tests: anti-VEGF medication A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema NCT07812090Phase 216 sites📍 Bakersfield📍 Glendale📍 Mountain View BioAge Labs, Inc. · Tests: Oral BGE-102, Oral Placebo Matching BGE-102, Anti-VEGF, Sham A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO NCT07205887Phase 255 sites📍 Scottsdale📍 Scottsdale📍 Glendale EyeBiotech Ltd. · Tests: Remigromig, Aflibercept 2.0 mg High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy NCT06662994Phase 41 site📍 Fullerton Retina Consultants of Orange County · Tests: Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321) Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) NCT05802329Phase 15 sites📍 Deerfield Beach📍 Erie📍 Bellaire Ocugen · Tests: OCU200 A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005) NCT07705607Phase 319 sites📍 Waterford📍 Orlando📍 St. Petersburg Merck Sharp & Dohme LLC · Tests: MK-8748, Aflibercept Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema NCT07383701Phase 21 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: Lactobacillus plantarum 299v Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab NCT07520045NA1 site📍 Osijek Osijek University Hospital · Tests: Faricimab, Biosimilar ranibizumab Imaging Retinal Vasculature in Infant Eyes NCT05558059n/a2 sites📍 Durham📍 Philadelphi Duke University · Tests: Handheld Optical Coherence Tomography with OCT Angiography Patients With Type 2 Diabetes NCT07245082n/a1 site📍 Taipei National Taiwan University Hospital Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients NCT06929507NA2 sites📍 Alexandroupoli📍 Alexandroupoli University Hospital, Alexandroupolis · Tests: Intravitreal injection of Faricimab or Aflibercept 2 mg A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema NCT06962839Phase 297 sites📍 Phoenix📍 Arcadia📍 Huntington Beach Boehringer Ingelheim · Tests: BI 1815368, Placebo Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy NCT06549023NA1 site📍 Mölndal Vastra Gotaland Region · Tests: Single-session panretinal PRP (SS-PRP), Multiple-session panretinal PRP (MS-PRP) Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema NCT07295704n/a1 site📍 Cairo The General Authority for Teaching Hospitals and Institutes · Tests: Micropulse Laser Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema NCT03161652Phase 22 sites📍 Querétaro City📍 Querétaro City Carmen Clapp · Tests: DME lactose pill, DME levosulpiride, DR lactose pill, DR levosulpiride, DR vitrectomy lactose pill Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema NCT07515079Phase 350 sites📍 Beijing📍 Beijing📍 Chongqing Bio-Thera Solutions · Tests: BAT5906 injection, Lucentis Corticosteroid for Diabetic Macular Edema (DME) Study NCT07843849Phase 41 site📍 Nashville Vanderbilt University Medical Center · Tests: Intravitreal dexamethasone implant, Intravitreal dexamethasone implant High Resolution, High-speed Multimodal Ophthalmic Imaging NCT04129021NA1 site📍 Paris Centre Hospitalier National d'Ophtalmologie des Quinze-Ving… · Tests: High-resolution retinal imaging through adaptive optics, High-resolution retinal imaging through holographic systems A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated NCT07553429Phase 1, Phase 229 sites📍 Phoenix📍 Scottsdale📍 Arcadia Boehringer Ingelheim · Tests: Low dose BI 3812465, Medium dose BI 3812465, High dose BI 3812465 The PRIME Study: A Randomized, Controlled, Prospective Study NCT04549935Phase 41 site📍 Bozeman Vance Thompson Vision - MT · Tests: Dextenza, Topical Prednisolone Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents NCT07567833Phase 48 sites📍 Huntington Beach📍 Augusta📍 Boston Jaeb Center for Health Research · Tests: Anti-Vascular Endothelial Growth Factor Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients NCT07362927EARLY Phase 12 sites📍 Shanghai📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: LX111 Injection A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). NCT07867080Phase 387 sites📍 Scottsdale📍 Encino📍 Fullerton 4D Molecular Therapeutics · Tests: 4D-150 IVT (3x10^10 vg), EYELEA ® (aflibercept) Injection 2 mg (0.05mL) Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular Edema NCT07708142Phase 31 site📍 Seoul SANGMYUNG innovation · Tests: Reference Drug, SMO1 Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment NCT07133438Phase 41 site📍 Chongqing First Affiliated Hospital of Chongqing Medical University · Tests: Anti-VEGF drug, Mecobalamin 5 MG, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy